Search Results - "Taminiau, Jan Ajm"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial by Bongers, Marloes E J, de Lorijn, Fleur, Reitsma, Johannes B, Groeneweg, Michael, Taminiau, Jan A J M, Benninga, Marc A

    Published in Nutrition journal (11-04-2007)
    “…Nutrilon Omneo (new formula; NF) contains high concentration of sn-2 palmitic acid, a mixture of prebiotic oligosaccharides and partially hydrolyzed whey…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Infliximab Use in Children and Adolescents With Inflammatory Bowel Disease by Ridder, Lissy, Benninga, Marc A, Taminiau, Jan AJM, Hommes, Daan W, Deventer, Sander JH

    “…ABSTRACT Infliximab is a chimeric monoclonal antibody (75% human, 25% murine) against tumor necrosis factor‐α, a cytokine with a central role in the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Short-term protein intake and stimulation of protein synthesis in stunted children with cystic fibrosis by Geukers, V.G.M, Oudshoorn, J.H, Taminiau, J.A.J.M, Ent, C.K van der, Schilte, P, Ruiter, A.F.C, Ackermans, M.T, Endert, E, Jonkers-Schuitema, C.F, Heymans, H.S.A

    Published in The American journal of clinical nutrition (01-03-2005)
    “…Background: Stunted children with cystic fibrosis (CF) have less net protein anabolism than do children without CF, and the result is retarded growth in the CF…”
    Get full text
    Journal Article
  6. 6
  7. 7